Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial. / Sørensen, Camilla Adler; Fuglsang, Eva; Jørgensen, Charlotte Sværke; Laursen, Rikke Pilmann; Larnkjær, Anni; Mølgaard, Christian; Ritz, Christian; Michaelsen, Kim F.; Krogfelt, Karen Angeliki; Frøkiær, Hanne.

I: Clinical Microbiology and Infection, Bind 25, Nr. 4, 2019, s. 511.e1-511.e7.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Sørensen, CA, Fuglsang, E, Jørgensen, CS, Laursen, RP, Larnkjær, A, Mølgaard, C, Ritz, C, Michaelsen, KF, Krogfelt, KA & Frøkiær, H 2019, 'Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial', Clinical Microbiology and Infection, bind 25, nr. 4, s. 511.e1-511.e7. https://doi.org/10.1016/j.cmi.2018.07.031

APA

Sørensen, C. A., Fuglsang, E., Jørgensen, C. S., Laursen, R. P., Larnkjær, A., Mølgaard, C., ... Frøkiær, H. (2019). Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial. Clinical Microbiology and Infection, 25(4), 511.e1-511.e7. https://doi.org/10.1016/j.cmi.2018.07.031

Vancouver

Sørensen CA, Fuglsang E, Jørgensen CS, Laursen RP, Larnkjær A, Mølgaard C o.a. Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial. Clinical Microbiology and Infection. 2019;25(4):511.e1-511.e7. https://doi.org/10.1016/j.cmi.2018.07.031

Author

Sørensen, Camilla Adler ; Fuglsang, Eva ; Jørgensen, Charlotte Sværke ; Laursen, Rikke Pilmann ; Larnkjær, Anni ; Mølgaard, Christian ; Ritz, Christian ; Michaelsen, Kim F. ; Krogfelt, Karen Angeliki ; Frøkiær, Hanne. / Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial. I: Clinical Microbiology and Infection. 2019 ; Bind 25, Nr. 4. s. 511.e1-511.e7.

Bibtex

@article{71303e422f7248969b44f78dee3a08e8,
title = "Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial",
abstract = "Objectives: To examine the effect of a combination of probiotics on the antibody response to pneumococcal and pertussis vaccination in Danish healthy children, aged 8-14 months, at the time of starting day care. Moreover, the cytokine response to LPS of whole blood was assessed.Methods: A total of 290 children were randomly allocated to receive a combination of Bifidobacterium animalis ssp. lactis and Lactobacillus rhamnosus GG daily for a six month intervention period, and blood samples were drawn at start and end of the study. Specific antibody response towards Streptococcus pneumoniae serotypes and Bordetella pertussis toxin, as well as endotoxin induced IL-6 and IFN-γ production in blood were analysed by Luminex and ELISA.Results: There was no significant difference between the average individual changes (AIC) from baseline to end of study in antibody concentrations for S. pneumoniae for both the probiotics (340.4{\%} ± 11.2{\%}) and the placebo group (382.9{\%} ± 10.4{\%}) (p = 0.525), nor for B. pertussis toxin in the two groups (probiotics 190.1{\%} ± 12.6{\%} vs placebo 238.8{\%} ± 1.1{\%}, p = 0.340). The AIC in IL-6 concentration was significantly lower in the probiotics vs. placebo group (2.9{\%} ± 10.3{\%} vs. 33.7{\%} ± 9.0{\%}, p = 0.024), whereas there was no difference in IFN-γ concentration (0.0{\%} ± 0.2{\%} vs. -0.2{\%} ± 0.1{\%}, p = 0.279).Conclusions: The probiotic intervention did not affect the antibody response against S. pneumoniae and B. pertussis toxin in healthy Danish children.",
keywords = "Faculty of Science, Cytokine activation, Pertussis, Placebo-controlled study, Pneumococcus, Probiotics, Vaccination response",
author = "S{\o}rensen, {Camilla Adler} and Eva Fuglsang and J{\o}rgensen, {Charlotte Sv{\ae}rke} and Laursen, {Rikke Pilmann} and Anni Larnkj{\ae}r and Christian M{\o}lgaard and Christian Ritz and Michaelsen, {Kim F.} and Krogfelt, {Karen Angeliki} and Hanne Fr{\o}ki{\ae}r",
note = "CURIS 2018 NEXS 317",
year = "2019",
doi = "10.1016/j.cmi.2018.07.031",
language = "English",
volume = "25",
pages = "511.e1--511.e7",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial

AU - Sørensen, Camilla Adler

AU - Fuglsang, Eva

AU - Jørgensen, Charlotte Sværke

AU - Laursen, Rikke Pilmann

AU - Larnkjær, Anni

AU - Mølgaard, Christian

AU - Ritz, Christian

AU - Michaelsen, Kim F.

AU - Krogfelt, Karen Angeliki

AU - Frøkiær, Hanne

N1 - CURIS 2018 NEXS 317

PY - 2019

Y1 - 2019

N2 - Objectives: To examine the effect of a combination of probiotics on the antibody response to pneumococcal and pertussis vaccination in Danish healthy children, aged 8-14 months, at the time of starting day care. Moreover, the cytokine response to LPS of whole blood was assessed.Methods: A total of 290 children were randomly allocated to receive a combination of Bifidobacterium animalis ssp. lactis and Lactobacillus rhamnosus GG daily for a six month intervention period, and blood samples were drawn at start and end of the study. Specific antibody response towards Streptococcus pneumoniae serotypes and Bordetella pertussis toxin, as well as endotoxin induced IL-6 and IFN-γ production in blood were analysed by Luminex and ELISA.Results: There was no significant difference between the average individual changes (AIC) from baseline to end of study in antibody concentrations for S. pneumoniae for both the probiotics (340.4% ± 11.2%) and the placebo group (382.9% ± 10.4%) (p = 0.525), nor for B. pertussis toxin in the two groups (probiotics 190.1% ± 12.6% vs placebo 238.8% ± 1.1%, p = 0.340). The AIC in IL-6 concentration was significantly lower in the probiotics vs. placebo group (2.9% ± 10.3% vs. 33.7% ± 9.0%, p = 0.024), whereas there was no difference in IFN-γ concentration (0.0% ± 0.2% vs. -0.2% ± 0.1%, p = 0.279).Conclusions: The probiotic intervention did not affect the antibody response against S. pneumoniae and B. pertussis toxin in healthy Danish children.

AB - Objectives: To examine the effect of a combination of probiotics on the antibody response to pneumococcal and pertussis vaccination in Danish healthy children, aged 8-14 months, at the time of starting day care. Moreover, the cytokine response to LPS of whole blood was assessed.Methods: A total of 290 children were randomly allocated to receive a combination of Bifidobacterium animalis ssp. lactis and Lactobacillus rhamnosus GG daily for a six month intervention period, and blood samples were drawn at start and end of the study. Specific antibody response towards Streptococcus pneumoniae serotypes and Bordetella pertussis toxin, as well as endotoxin induced IL-6 and IFN-γ production in blood were analysed by Luminex and ELISA.Results: There was no significant difference between the average individual changes (AIC) from baseline to end of study in antibody concentrations for S. pneumoniae for both the probiotics (340.4% ± 11.2%) and the placebo group (382.9% ± 10.4%) (p = 0.525), nor for B. pertussis toxin in the two groups (probiotics 190.1% ± 12.6% vs placebo 238.8% ± 1.1%, p = 0.340). The AIC in IL-6 concentration was significantly lower in the probiotics vs. placebo group (2.9% ± 10.3% vs. 33.7% ± 9.0%, p = 0.024), whereas there was no difference in IFN-γ concentration (0.0% ± 0.2% vs. -0.2% ± 0.1%, p = 0.279).Conclusions: The probiotic intervention did not affect the antibody response against S. pneumoniae and B. pertussis toxin in healthy Danish children.

KW - Faculty of Science

KW - Cytokine activation

KW - Pertussis

KW - Placebo-controlled study

KW - Pneumococcus

KW - Probiotics

KW - Vaccination response

U2 - 10.1016/j.cmi.2018.07.031

DO - 10.1016/j.cmi.2018.07.031

M3 - Journal article

C2 - 30099133

VL - 25

SP - 511.e1-511.e7

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 4

ER -

ID: 201039134